Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biometrics
|
March 1, 1988
Mixed Poisson likelihood regression models for longitudinal interval count data
P F Thall
Biometrics
|
June 1, 1994
Practical Bayesian guidelines for phase IIB clinical trials
P F Thall, R Simon
Biometrics
|
January 5, 2002
Decision-theoretic designs for pre-phase II screening trials in oncology
N Stallard, P F Thall
Biometrics
|
April 21, 2001
Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials
P F Thall, S C Cheng
Biometrics
|
April 17, 1998
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials
P F Thall, K E Russell
Biometrics
|
September 1, 1990
Some covariance models for longitudinal count data with overdispersion
P F Thall, S C Vail
Biometrics
|
April 21, 2001
Decision theoretic designs for phase II clinical trials with multiple outcomes
N Stallard, P F Thall, J Whitehead
Biometrics
|
September 12, 2001
Dose-finding based on feasibility and toxicity in T-cell infusion trials
P F Thall, H G Sung, A Choudhury
Biometrics
|
June 1, 1989
Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoring
M Halperin, M I Hamdy, P F Thall
Biometrics
|
January 10, 1998
Semiparametric regression analysis for recurrent event interval counts
J G Staniswalis, P F Thall, J Salch
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biometrics
|
March 1, 1988
Mixed Poisson likelihood regression models for longitudinal interval count data
P F Thall
Biometrics
|
June 1, 1994
Practical Bayesian guidelines for phase IIB clinical trials
P F Thall, R Simon
Biometrics
|
January 5, 2002
Decision-theoretic designs for pre-phase II screening trials in oncology
N Stallard, P F Thall
Biometrics
|
April 21, 2001
Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials
P F Thall, S C Cheng
Biometrics
|
April 17, 1998
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials
P F Thall, K E Russell
Biometrics
|
September 1, 1990
Some covariance models for longitudinal count data with overdispersion
P F Thall, S C Vail
Biometrics
|
April 21, 2001
Decision theoretic designs for phase II clinical trials with multiple outcomes
N Stallard, P F Thall, J Whitehead
Biometrics
|
September 12, 2001
Dose-finding based on feasibility and toxicity in T-cell infusion trials
P F Thall, H G Sung, A Choudhury
Biometrics
|
June 1, 1989
Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoring
M Halperin, M I Hamdy, P F Thall
Biometrics
|
January 10, 1998
Semiparametric regression analysis for recurrent event interval counts
J G Staniswalis, P F Thall, J Salch
Page
of 2